Magnes Res. 2024 Nov 1;37(2):61-75. doi: 10.1684/mrh.2024.0528.
This study aimed to evaluate the relationship between magnesium (Mg) status, serum vitamin D (VD) concentration and mortality in congestive heart failure (CHF) patients. Data for this study were extracted from the National Health and Nutrition Examination Surveys 2007-2018. Magnesium depletion score (MDS) is a scoring system developed to predict the status of Mg deficiency that considers the pathophysiological factors influencing the reabsorption capability of the kidneys. The primary outcome was all-cause mortality of CHF patients and the secondary outcome was mortality due to cardiovascular disease (CVD). Weighted univariate and multivariate cox proportional hazards models were used to explore the association between Mg status, serum VD concentration and all-cause mortality or mortality due to CVD in CHF patients, using hazard ratios (HRs) and 95 % confidence intervals (CIs). Subgroup analyses based on age, physical activity (PA), course of CHF, race, and body mass index were further assessed with regards to the association analysis. In total, 1022 CHF patients were included, of whom 418 (40.90 %) died by 31st December 2019. After adjusting for all covariates, high MDS (>2 points) was related to a higher risk of all-cause mortality (HR = 1.72, 95 % CI: 1.30-2.29) and mortality due to CVD (HR = 1.71, 95 % CI: 1.29-2.25); a higher serum VD concentration was related to a lower risk of all-cause mortality (HR = 0.78, 95 %CI: 0.62-0.99) and mortality due to CVD (HR = 0.80, 95 % CI: 0.63-0.99). Compared to patients with high serum VD concentration and low MDS, patients with low serum VD concentration and high MDS had a high risk of all-cause mortality (HR = 2.44, 95 % CI: 1.54-3.85, p for trend = 0.043) and mortality due to CVD (HR = 2.41, 95 % CI: 1.32-4.40). Serum VD and Mg status may have a combined effect in improving the prognosis in CHF patients, thus an appropriate level of serum VD and Mg intake may be beneficial to maintain cardiovascular health, thereby improving outcome.
本研究旨在评估镁(Mg)状态、血清维生素 D(VD)浓度与充血性心力衰竭(CHF)患者死亡率之间的关系。本研究的数据来自 2007-2018 年的国家健康和营养调查。镁耗竭评分(MDS)是一种评分系统,用于预测 Mg 缺乏状态,该系统考虑了影响肾脏重吸收能力的病理生理因素。主要结局是 CHF 患者的全因死亡率,次要结局是心血管疾病(CVD)导致的死亡率。使用风险比(HRs)和 95%置信区间(CIs),采用加权单变量和多变量 Cox 比例风险模型探讨了 Mg 状态、血清 VD 浓度与 CHF 患者全因死亡率或 CVD 死亡率之间的关系。根据年龄、体力活动(PA)、CHF 病程、种族和体重指数进一步进行了亚组分析,以评估关联分析。共有 1022 例 CHF 患者纳入本研究,其中 418 例(40.90%)于 2019 年 12 月 31 日死亡。在调整所有协变量后,高 MDS(>2 分)与全因死亡率(HR=1.72,95%CI:1.30-2.29)和 CVD 死亡率(HR=1.71,95%CI:1.29-2.25)升高相关;较高的血清 VD 浓度与全因死亡率(HR=0.78,95%CI:0.62-0.99)和 CVD 死亡率(HR=0.80,95%CI:0.63-0.99)降低相关。与高血清 VD 浓度和低 MDS 的患者相比,低血清 VD 浓度和高 MDS 的患者全因死亡率(HR=2.44,95%CI:1.54-3.85,p 趋势=0.043)和 CVD 死亡率(HR=2.41,95%CI:1.32-4.40)风险较高。血清 VD 和 Mg 状态可能对改善 CHF 患者预后具有协同作用,因此适当的血清 VD 和 Mg 摄入可能有利于维持心血管健康,从而改善预后。